PIPE-307 Misses Key Endpoints in RRMS: What Contin...
Category : Clinical Trial Update 24 November 2025Contineum Therapeutics has shared topline results from its Phase 2 VISTA trial of PIPE-307, an oral...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Mesoblast and NIH’s BMT CTN Launch Pivotal Trial f...
Category : Clinical Trial Update 24 November 2025Mesoblast has announced a major step toward expanding treatment options for adults with severe acute...
Meril’s Myval THV Proves Its Strength in Landmark...
Category : Clinical Trial Update 24 November 2025Meril Life Sciences has unveiled the one-year results from its pivotal LANDMARK randomized controlle...
Bayer Posts Positive Phase III Results for Asundex...
Category : Clinical Trial Update 24 November 2025German pharmaceutical leader Bayer has reported encouraging Phase III results for asundexian, its ne...
FDA Grants First-Ever EUA for Treating New World S...
Category : Approval/Launch 22 November 2025The U.S. FDA has issued a historic Emergency Use Authorization (EUA) for Elanco’s Credelio&tra...
Latest Newsletter Post
-
Bayer Posts Positive Phase III Resu..
24 November 2025
-
Meril’s Myval THV Proves Its Streng..
24 November 2025
-
Mesoblast and NIH’s BMT CTN Launch..
24 November 2025
-
PIPE-307 Misses Key Endpoints in RR..
24 November 2025
-
Eli Lilly Joins the $1 Trillion Clu..
22 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com